Renaissance Technologies (RenTech)'s CAI Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 329,900 shares of Caris Life Sciences, Inc. (CAI) worth $8.9 M, representing 0.01% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Renaissance Technologies (RenTech) has initiated a new position in CAI, representing a fresh investment thesis on this company. Largest addition occurred in Q4 2025, adding 104,800 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Caris Life Sciences (CAI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Caris Life Sciences (CAI) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +104,800 | Add 46.56% | 329,900 | $26.98 |
| Q3 2025 | +225,100 | New Buy | 225,100 | $30.25 |
Renaissance Technologies (RenTech)'s Caris Life Sciences Investment FAQs
Renaissance Technologies (RenTech) first purchased Caris Life Sciences, Inc. (CAI) in Q3 2025, acquiring 225,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Caris Life Sciences, Inc. (CAI) for 2 quarters since Q3 2025.
Renaissance Technologies (RenTech)'s largest addition to Caris Life Sciences, Inc. (CAI) was in Q3 2025, adding 225,100 shares worth $6.81 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 329,900 shares of Caris Life Sciences, Inc. (CAI), valued at approximately $8.9 M.
As of the Q4 2025 filing, Caris Life Sciences, Inc. (CAI) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Caris Life Sciences, Inc. (CAI) was 329,900 shares, as reported at the end of Q4 2025.